Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis Vandergriff

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
JAAD Case Reports|December 30, 2022
Fibroblast growth factor receptor inhibitor therapy induced calcinosis cutis treated with sodium thiosulfateJustin Qian, Jeffrey N Li, Elysha K Rose, et al.
Science Signaling|February 26, 2015
The E3 ubiquitin ligase Itch inhibits p38α signaling and skin inflammation through the ubiquitylation of Tab1Balamayooran Theivanthiran, Mahesh Kathania, Minghui Zeng, et al.
Human Pathology|April 11, 2025
Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasmsHanan Hamdan, Alexa Siddon, Maximiliano Ramia de Cap, et al.
Journal of Cutaneous Pathology|February 28, 2015
Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous LymphomasTravis Vandergriff, Kaveh A Nezafati, Joseph Susa, et al.
The British Journal of Dermatology|March 4, 2025
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stromaSimon F Roy, Nnenna G Agim, Adnan Mir, et al.
Nature Communications|August 23, 2016
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUgur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Journal of the American Academy of Dermatology|January 2, 2017
Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatosesKhang D Nguyen, Eunice E Lee, Yangbo Yue, et al.
Nature Communications|September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUgur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Nature Medicine|April 18, 2018
Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasisZhuzhen Zhang, Zhenzhen Zi, Eunice E Lee, et al.
Nature|December 20, 2019
Metabolic heterogeneity confers differences in melanoma metastatic potentialAlpaslan Tasdogan, Brandon Faubert, Vijayashree Ramesh, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
JAAD Case Reports|December 30, 2022
Fibroblast growth factor receptor inhibitor therapy induced calcinosis cutis treated with sodium thiosulfateJustin Qian, Jeffrey N Li, Elysha K Rose, et al.
Science Signaling|February 26, 2015
The E3 ubiquitin ligase Itch inhibits p38α signaling and skin inflammation through the ubiquitylation of Tab1Balamayooran Theivanthiran, Mahesh Kathania, Minghui Zeng, et al.
Human Pathology|April 11, 2025
Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasmsHanan Hamdan, Alexa Siddon, Maximiliano Ramia de Cap, et al.
Journal of Cutaneous Pathology|February 28, 2015
Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous LymphomasTravis Vandergriff, Kaveh A Nezafati, Joseph Susa, et al.
The British Journal of Dermatology|March 4, 2025
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stromaSimon F Roy, Nnenna G Agim, Adnan Mir, et al.
Nature Communications|August 23, 2016
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUgur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Journal of the American Academy of Dermatology|January 2, 2017
Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatosesKhang D Nguyen, Eunice E Lee, Yangbo Yue, et al.
Nature Communications|September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUgur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Nature Medicine|April 18, 2018
Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasisZhuzhen Zhang, Zhenzhen Zi, Eunice E Lee, et al.
Nature|December 20, 2019
Metabolic heterogeneity confers differences in melanoma metastatic potentialAlpaslan Tasdogan, Brandon Faubert, Vijayashree Ramesh, et al.
Pageof 11